These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36397309)

  • 21. Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers.
    Li M; Zhao L; Zhang T; Shu Y; He Z; Ma Y; Liu D; Wang Y
    Acta Pharm Sin B; 2019 Mar; 9(2):421-432. PubMed ID: 30972286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy.
    Guo J; Zhang X; Dong F; Wang S; Wang D; Li Y; Zuo S; Wang Q; Li W; Sun J; He Z; Zhang T; Jiang Q; Sun B
    J Colloid Interface Sci; 2025 Jan; 677(Pt A):941-952. PubMed ID: 39128288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy.
    Zhang Y; Zhang H; Wang J; Liu C; Xing H; Jiang Y; Li X
    Mol Pharm; 2023 May; 20(5):2513-2526. PubMed ID: 37071030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy.
    Zhong ZX; Li XZ; Liu JT; Qin N; Duan HQ; Duan XC
    Int J Nanomedicine; 2023; 18():1281-1298. PubMed ID: 36945256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel prodrug self-assembled nanosystem: Synthesis, formulation and cytotoxicity.
    Jing F; Guo Q; Xu W; Qu H; Sui Z
    Bioorg Med Chem Lett; 2018 Feb; 28(4):826-830. PubMed ID: 29395972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing the Impact of Surface Functionalization Module on the Performance of Mitoxantrone Prodrug Nanoassemblies: Improving the Effectiveness and Safety.
    Zhang B; Li L; Huang M; Zhao E; Li Y; Sun J; He Z; Fu C; Liu G; Sun B
    Nano Lett; 2024 Mar; 24(12):3759-3767. PubMed ID: 38478977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Satellite-Type Sulfur Atom Distribution in Trithiocarbonate Bond-Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability.
    Li L; Liu T; Zuo S; Li Y; Zhao E; Lu Q; Wang D; Sun Y; He Z; Sun B; Sun J
    Adv Mater; 2024 Jan; 36(4):e2310633. PubMed ID: 37983894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity.
    Li G; Sun B; Zheng S; Xu L; Tao W; Zhao D; Yu J; Fu S; Zhang X; Zhang H; Zhai Y; Luo C; Ding H; He Z; Sun J
    Adv Healthc Mater; 2021 Dec; 10(23):e2101407. PubMed ID: 34601824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon-Spaced Tandem-Disulfide Bond Bridge Design Addresses Limitations of Homodimer Prodrug Nanoassemblies: Enhancing Both Stability and Activatability.
    Zhang H; Liu T; Sun Y; Wang S; Wang W; Kuang Z; Duan M; Du T; Liu M; Wu L; Sun F; Sheng J; He Z; Sun J
    J Am Chem Soc; 2024 Aug; 146(32):22675-22688. PubMed ID: 39088029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity.
    Ren G; Duan D; Wang G; Wang R; Li Y; Zuo H; Zhang Q; Zhang G; Zhao Y; Wang R; Zhang S
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112614. PubMed ID: 35700564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer.
    Wei W; Luo C; Yang J; Sun B; Zhao D; Liu Y; Wang Y; Yang W; Kan Q; Sun J; He Z
    J Control Release; 2018 Sep; 285():187-199. PubMed ID: 30017721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel.
    Cui W; Zhang S; Zhao H; Luo C; Sun B; Li Z; Sun M; Ye Q; Sun J; He Z
    Biomater Sci; 2019 Feb; 7(3):1117-1131. PubMed ID: 30638237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
    Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
    Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy.
    Lu S; Hao D; Xiang X; Pei Q; Xie Z
    J Control Release; 2023 Mar; 355():528-537. PubMed ID: 36787820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy.
    Li Y; Li L; Jin Q; Liu T; Sun J; Wang Y; Yang Z; He Z; Sun B
    Asian J Pharm Sci; 2022 Mar; 17(2):241-252. PubMed ID: 35582643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A responsive disulfide bond switch aptamer prodrug exhibiting enhanced stability and anticancer efficacy.
    Dong X; Zhang Z; Zhao T; Chen Z; Wang J; Xu L; Zhang A
    Bioorg Med Chem Lett; 2024 May; 104():129729. PubMed ID: 38583786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents.
    Lei J; Zhang Q; Jin X; Lu H; Wang S; Li T; Sheng Y; Zhang F; Zheng Y
    Mol Pharm; 2021 Jul; 18(7):2777-2785. PubMed ID: 34121410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
    Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
    Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disulfide bond based cascade reduction-responsive Pt(IV) nanoassemblies for improved anti-tumor efficiency and biosafety.
    Kuang X; Chi D; Li J; Guo C; Yang Y; Zhou S; Luo C; Liu H; He Z; Wang Y
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111766. PubMed ID: 33866279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.